|
Commenting on the new FDA approval of tetrabenazine, Dr. Martha Nance, Director of the Huntington's Disease Clinic at Hennepin noted: “This is a historic time in the history of Huntington’s Disease research, because for the first time, a drug has been approved for use in HD! Tetrabenazine is only a treatment for chorea, and it will not change the course of the disease, but improving the quality of life for people with HD is a big step in the right direction! We expect the drug to be available in pharmacies by December, so those with HD and their families should talk to their doctors to see if this would be an appropriate treatment for them.” The Huntington's Disease Center of Excellence at Hennepin County Medical Center (HCMC) has provided care in the Upper Midwest for patients and families with HD since 1978. It was established through the individual efforts of Sally Hogan, a spouse and mother of HD-affected individuals, and Dr. Milton Ettinger, the now retired Chief of Neurology. We have cared for hundreds of patients and families touched by HD over the past 25 years. The multidisciplinary HD team of care providers, in addition to providing patient care, has provided educational services for a number of students of nursing, medicine, genetic counseling, psychology, neuropsychology, chaplaincy, physical therapy, occupatinal therapy, dietary and speechpathology Special Note: We would like to acknowledge and thank the HCMC Service League for providing grant funds to help maintain these web pages.
|

HDSA
Center of Excellence at Hennepin County Medical Center